Skip to main content
Caplight Logo









EOC Pharma

EOC Pharma

Private
ShanghaiHealthcare & Life Scienceshttps://www.eocpharma.com/

Last Round

Series C

Dec 2, 2019

Total Funding Raised

$103.1M

Company Overview

EOC Pharma is a biopharmaceutical company that focuses on the discovery, research, development, and commercialization of innovative oncology products for the Chinese market.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

oncologybiopharmaceuticaldrug developmentin-licensingcancer therapyclinical trialsbiotechNMPA approvalimmunotherapysmall moleculedrug commercializationpharma licensingprecision medicinecGMP manufacturingbiologics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EOC Pharma Comparables

Compare EOC Pharma with similar companies based on industry and business-model similarity.

EOC Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Xynomic Pharmaceuticals
84%
Zai Lab Limited
81%
Genor BioPharma
77%

EOC Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CDec 2, 2019
Series BNov 7, 2017

EOC Pharma Investors

Notable investors and investment history

EOC Pharma investors
InvestorRounds
TF CapitalSeries C
H&Q Asia PacificSeries B
Yingke PESeries C
HongShan Capital Group (HSG)Series B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Monthly visitors grew 190% MoM, from 415 to 1.2K.

EOC Pharma Filings

Explore SEC and related filing metadata, where available.

EOC Pharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EOC Pharma's valuation, stock price, and market status.

Is EOC Pharma a public or private company?

EOC Pharma is a private company.

What is the current stock price of EOC Pharma?

EOC Pharma is a private company with no public stock price. No recent secondary market data is available.

How much is EOC Pharma worth (valuation)?

Valuation information for EOC Pharma is not publicly available.

Can I buy EOC Pharma stock?

EOC Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EOC Pharma's last funding round?

EOC Pharma's most recent funding round was Series C on December 2, 2019.

Who are the main investors in EOC Pharma?

Key investors in EOC Pharma include TF Capital, HongShan, Yingke PE.

Will EOC Pharma IPO soon?

No public IPO plans have been announced for EOC Pharma.

How can I track EOC Pharma secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EOC Pharma's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersShanghai
Employee Range3
Year Founded2015
Last FundingDec 2, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?